ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL.
Why invest in ValiRx
ValiRx is a fast-growing drug development company focused on identifying novel science with high potential for successful development into products that improve the lives of patients throughout treatment.
The company reduces the risk of development by providing intellectual, corporate and financial support in the early stages of development, creating value for both innovators and investors. Clinical trials of successful projects are managed through independently funded subsidiaries.
ValiRx provides support to these subsidiaries, covering its working capital needs through an appropriate fee structure.